{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:26:49Z","timestamp":1790018809131,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":5885,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1038\/labinvest.3700487","type":"journal-article","created":{"date-parts":[[2006,10,30]],"date-time":"2006-10-30T16:25:50Z","timestamp":1162225550000},"page":"1243-1260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Early pathogenic events associated with Sj\u00f6gren's syndrome (SjS)-like disease of the nod mouse using microarray analysis"],"prefix":"10.1016","volume":"86","author":[{"given":"Smruti Y","family":"Killedar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Eckenrode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"McIndoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Xiong","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuong Q","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammon B","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghee R","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.3700487_bib1","series-title":"Arthritis and Allied Conditions\u2014A Textbook in Rheumatology","first-page":"1681","article-title":"Sj\u00f6gren's syndrome","author":"Jonsson","year":"2004"},{"key":"10.1038\/labinvest.3700487_bib2","first-page":"1896","article-title":"Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjogren's syndrome-like autoimmune exocrinopathy","volume":"27","author":"Brayer","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1038\/labinvest.3700487_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-3083.2001.00958.x","article-title":"IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjogren's syndrome","volume":"54","author":"Brayer","year":"2001","journal-title":"Scand J Immunol"},{"key":"10.1038\/labinvest.3700487_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/154411130201300103","article-title":"Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update","volume":"13","author":"Cha","year":"2002","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1038\/labinvest.3700487_bib5","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","article-title":"Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome","volume":"95","author":"Robinson","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.3700487_bib6","first-page":"2371","article-title":"Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjogren's syndrome","volume":"25","author":"Yamachika","year":"1998","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"10.1038\/labinvest.3700487_bib7","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0003-9969(99)90008-0","article-title":"New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model","volume":"44","author":"Humphreys-Beher","year":"1999","journal-title":"Arch Oral Biol"},{"key":"10.1038\/labinvest.3700487_bib8","first-page":"296","article-title":"Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjogren's syndrome-associated autoantibodies","volume":"33","author":"Cha","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1038\/labinvest.3700487_bib9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/978-1-4615-2417-5_105","article-title":"Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjogren's syndrome","volume":"350","author":"Humphreys-Beher","year":"1994","journal-title":"Adv Exp Med Biol"},{"key":"10.1038\/labinvest.3700487_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T","article-title":"A novel NOD-derived murine model of primary Sjogren's syndrome","volume":"41","author":"Robinson","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.3700487_bib11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0002-9440(10)65027-4","article-title":"Severe destructive autoimmune lesions with aging in murine Sjogren's syndrome through Fas-mediated apoptosis","volume":"156","author":"Ishimaru","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.3700487_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.3700487_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/clin.1996.0050","article-title":"Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice","volume":"79","author":"Robinson","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1038\/labinvest.3700487_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2004.04993.x","article-title":"Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma","volume":"126","author":"Ambrosetti","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1038\/labinvest.3700487_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000049194","article-title":"Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy","volume":"18","author":"Cha","year":"2001","journal-title":"Exp Clin Immunogenet"},{"key":"10.1038\/labinvest.3700487_bib16","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X","article-title":"Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in nod mice","volume":"43","author":"Nguyen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.3700487_bib17","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/art.20371","article-title":"Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjogren's syndrome patients by use of a transfected cell line assay","volume":"50","author":"Gao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.3700487_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.0300-9475.2004.01395.x","article-title":"Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjogren's syndrome","volume":"59","author":"Cavill","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1038\/labinvest.3700487_bib19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1046\/j.1365-2249.2001.01526.x","article-title":"Acetylcholine-evoked calcium mobilization and ion channel activation in human labial gland acinar cells from patients with primary Sjogren's syndrome","volume":"124","author":"Dawson","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/labinvest.3700487_bib20","first-page":"27","article-title":"Inhibitory effects of autoantibodies on the muscarinic receptors in Sjogren's syndrome","volume":"27","author":"Li","year":"2004","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.3700487_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s003359900097","article-title":"Production of congenic mouse strains carrying NOD-derived diabetogenic genetic intervals: an approach for the genetic dissection of complex traits","volume":"7","author":"Yui","year":"1996","journal-title":"Mamm Genome"},{"key":"10.1038\/labinvest.3700487_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF00361383","article-title":"Characterizations of candidate genes for IDD susceptibility from the diabetes-prone NOD mouse strain","volume":"4","author":"Chesnut","year":"1993","journal-title":"Mamm Genome"},{"key":"10.1038\/labinvest.3700487_bib23","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.10258","article-title":"Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjogren's syndrome) on a healthy murine background","volume":"46","author":"Cha","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.3700487_bib24","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.2006419","article-title":"Cadherin cell adhesion receptors as a morphogenetic regulator","volume":"251","author":"Takeichi","year":"1991","journal-title":"Science"},{"key":"10.1038\/labinvest.3700487_bib25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2337\/diabetes.53.2.366","article-title":"Gene expression profiles define a key checkpoint for type 1 diabetes in NOD mice","volume":"53","author":"Eckenrode","year":"2004","journal-title":"Diabetes"},{"key":"10.1038\/labinvest.3700487_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2249.1999.00888.x","article-title":"The role of apoptosis in the initiation of the autoimmune response in Sjogren's syndrome","volume":"116","author":"Humphreys-Beher","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/labinvest.3700487_bib27","doi-asserted-by":"crossref","first-page":"41624","DOI":"10.1074\/jbc.M207852200","article-title":"Caspase-11 gene expression in response to lipopolysaccharide and interferon-gamma requires nuclear factor-kappa B and signal transducer and activator of transcription (STAT) 1","volume":"277","author":"Schauvliege","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700487_bib28","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1073\/pnas.94.11.5767","article-title":"Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjogren syndrome","volume":"94","author":"Robinson","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.3700487_bib29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.275.5297.206","article-title":"Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme","volume":"275","author":"Gu","year":"1997","journal-title":"Science"},{"key":"10.1038\/labinvest.3700487_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.0300-9475.2004.01508.x","article-title":"A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse","volume":"60","author":"Cha","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1038\/labinvest.3700487_bib31","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1074\/jbc.M008099200","article-title":"Isolation of a 40-kDa Huntingtin-associated protein","volume":"276","author":"Peters","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700487_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.gene.2004.04.024","article-title":"Functional analysis of the rat cytochrome c oxidase subunit 6A1 promoter in primary neurons","volume":"337","author":"Ongwijitwat","year":"2004","journal-title":"Gene"},{"key":"10.1038\/labinvest.3700487_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0092-8674(00)80226-3","article-title":"Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras","volume":"89","author":"Rodriguez-Viciana","year":"1997","journal-title":"Cell"},{"key":"10.1038\/labinvest.3700487_bib34","doi-asserted-by":"crossref","first-page":"23630","DOI":"10.1074\/jbc.M300997200","article-title":"Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4\/c-Jun NH2-terminal kinase-dependent Pathways cooperate to maintain lung cancer cell survival","volume":"278","author":"Lee","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700487_bib35","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1038\/sj.onc.1208525","article-title":"ILK mediates actin filament rearrangements and cell migration and invasion through PI3K\/Akt\/Rac1 signaling","volume":"24","author":"Qian","year":"2005","journal-title":"Oncogene"},{"key":"10.1038\/labinvest.3700487_bib36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1139\/o04-114","article-title":"Wiring diagrams of MAPK regulation by MEKK1, 2, and 3","volume":"82","author":"Uhlik","year":"2004","journal-title":"Biochem Cell Biol"},{"key":"10.1038\/labinvest.3700487_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0925-4773(02)00350-7","article-title":"Rac-1 and IQGAP are potential regulators of E-cadherin-catenin interactions during murine preimplantation development","volume":"2","author":"Natale","year":"2002","journal-title":"Gene Expr Patterns"},{"key":"10.1038\/labinvest.3700487_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/intimm\/dxh354","article-title":"TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45","volume":"18","author":"Bryce","year":"2006","journal-title":"Int Immunol"},{"key":"10.1038\/labinvest.3700487_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2005.11.004","article-title":"Sjogren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease","volume":"26","author":"Gao","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1038\/labinvest.3700487_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature04369","article-title":"Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6","volume":"439","author":"Hacker","year":"2006","journal-title":"Nature"},{"key":"10.1038\/labinvest.3700487_bib41","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.4049\/jimmunol.173.12.7394","article-title":"Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation","volume":"173","author":"Ni","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.3700487_bib42","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.165.3.1322","article-title":"TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase","volume":"165","author":"Hatzoglou","year":"2000","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.3700487_bib43","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.4049\/jimmunol.161.9.4753","article-title":"NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27","volume":"161","author":"Yamamoto","year":"1998","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.3700487_bib44","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1073\/pnas.0500187102","article-title":"TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2\/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs","volume":"102","author":"Hauer","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.3700487_bib45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.coi.2005.04.005","article-title":"The role of APRIL and BAFF in lymphocyte activation","volume":"17","author":"Schneider","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1038\/labinvest.3700487_bib46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.1533","article-title":"Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome","volume":"202","author":"Lavie","year":"2004","journal-title":"J Pathol"},{"key":"10.1038\/labinvest.3700487_bib47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.62.2.168","article-title":"The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/labinvest.3700487_bib48","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.21006","article-title":"Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects","volume":"52","author":"Hjelmervik","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.3700487_bib49","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/atvb.21.12.1873","article-title":"Tumor necrosis factor receptor and ligand superfamily family members TNFRSF14 and LIGHT: new players in human atherogenesis","volume":"21","author":"Bobik","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/labinvest.3700487_bib50","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2567.2004.02004.x","article-title":"LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages","volume":"114","author":"Kim","year":"2005","journal-title":"Immunology"},{"key":"10.1038\/labinvest.3700487_bib51","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/art.10315","volume":"46","author":"Azuma","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.3700487_bib52","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0165-6147(97)01049-3","article-title":"Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?","volume":"18","author":"Teixeira","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1038\/labinvest.3700487_bib53","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.175.3.1523","article-title":"Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages","volume":"175","author":"Jin","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.3700487_bib54","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1096\/fasebj.7.11.8370480","article-title":"Autoimmune diabetes results from genetic defects manifest by antigen presenting cells","volume":"7","author":"Serreze","year":"1993","journal-title":"FASEB J"}],"updated-by":[{"DOI":"10.1038\/labinvest.3700542","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000}}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3700487.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3700487","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722017561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722017561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3700487.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T12:59:59Z","timestamp":1675947599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722017561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0023683722017561"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.3700487","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early pathogenic events associated with Sj\u00f6gren's syndrome (SjS)-like disease of the nod mouse using microarray analysis","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.3700487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.3700542","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}